drugset / Trial / NCT01638923
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate efficacy and safety of a combined oral contraceptive of estradiol valerate and dienogest in the treatment of heavy menstrual bleeding
Timeline
- Start
- 2012-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dienogest | Small molecule | 3 mg | Oral |
| Subject | estradiol valerate | Unknown | 2 mg | Oral |